Sharvil Patel

Rediff.com » News » Sharvil Patel

News for Sharvil Patel

News
Business

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila......

India's vaccine makers prepare to take on Omicron

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible. IMAGE: A lady shows......

Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

Cadila launches Remdesivir in India at Rs 2,800 per vial

Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. ......

Zydus gets China nod for kidney disease drug

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by......

US drug shortage a shot in the arm for Indian pharmaceutical companies

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Image used......

Cadila believes it has silver bullet to fight COVID-19

Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......

Sun Pharma's Dilip Shanghvi takes 99% pay cut

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore. The founder and managing director (MD) of the country’s largest pharmaceutical firm Sun......

'It was very hard to build an R&D set-up in India'

'In any organisation, a continuous line of leadership, is required.' 'All R&D will be of focus. All the way from Active Pharmaceutical Ingredients to R&D in formulations, to biologics, NCEs,......

Rediff News

Sharvil Patel

News for Sharvil Patel

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

India's vaccine makers prepare to take on Omicron

Govt developing multi-variant Covid-19 vaccine

Cadila launches Remdesivir in India at Rs 2,800 per vial

Zydus gets China nod for kidney disease drug

US drug shortage a shot in the arm for Indian pharmaceutical companies

Cadila believes it has silver bullet to fight COVID-19

Sun Pharma's Dilip Shanghvi takes 99% pay cut

'It was very hard to build an R&D set-up in India'

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS